Asciminib produced by Novartis subsidiary plant in Switzerland

TraditionalTKIs bind to the ATP binding pocket, in terms of toxicity, aceminib is well tolerated and may be better tolerated than bosutinib. But like many other chemotherapeutic agents, treatment with aceminib can cause various forms of myelosuppression, including thrombocytopenia and neutropenia. Patients should receive frequent laboratory monitoring throughout treatment and dose adjustments may be necessary based on the severity of the effects observed. Patients may also develop pancreatic and/or cardiovascular toxicities, both of which require frequent monitoring and may require dose adjustments based on prescribing information.

The original drug of Asiminib has not yet been launched in China, so it cannot be included in medical insurance. The original drug of Asiminib currently sold overseas is very expensive. Generic drugs of Asiminil are also produced and marketed overseas, and their drug ingredients are basically the same as those of the original drug. For example, the price of 40mg*60 tablets produced by a Laos pharmaceutical factory may be more than 4,000 yuan per box (the price may fluctuate due to exchange rate effects), and the price is relatively cheap. For more drug information and specific prices, please consult Yaode’s medical consultant.